Approval · Notice of Compliance 9898 · 2008
BOVATEC: Notice of Compliance 9898
Issued November 19, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9898
- Date
- November 19, 2008
- Company
- Alpharma Canada CorporationKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturer for the manufacturing of medicated minerals using bovatec
- Therapeutic class
- Antimicrobial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BOVATEC | 02242923 | Cancelled Post Market |
Medicinal ingredients
- LASALOCID SODIUM 150 G per KG